Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lakshmi Kotra Insider Profile
4 Followers
Lakshmi Kotra, Divisional Chief Executive Officer at Quantum Biopharma, holds 21.88K shares in Quantum Biopharma (Ticker: QNTM). Most recently, Lakshmi Kotra Sold $7,500 shares of Quantum Biopharma on Feb 08, 2025 for an estimated value of 168.61K.
Lakshmi Kotra has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Divisional Chief Executive Officer
Roles that Lakshmi Kotra holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Lakshmi Kotra
Lakshmi Kotra's Trading History
List of latest transactions for each holding click on a transaction to see Lakshmi Kotra's performance on stock
You May Also Like
Lakshmi Kotra insider profile FAQ
What is the percentage of profitable transactions made by Lakshmi Kotra?
The percentage of profitable transactions made by Lakshmi Kotra is ―.
What is the average return per transaction made by Lakshmi Kotra?
The average return per transaction made by Lakshmi Kotra is ―.
What stocks does Lakshmi Kotra hold?
Lakshmi Kotra holds: QNTM stocks.
What was Lakshmi Kotra’s latest transaction?
Lakshmi Kotra latest transaction was an Informative Sell of $168.61K.
What was Lakshmi Kotra's most profitable transaction?
Lakshmi Kotra’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Lakshmi Kotra's role in Quantum Biopharma?
Lakshmi Kotra's role in Quantum Biopharma is Divisional Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.